orabase and tilisolol

orabase has been researched along with tilisolol* in 2 studies

Other Studies

2 other study(ies) available for orabase and tilisolol

ArticleYear
Pharmacokinetic prediction of the ocular absorption of an instilled drug with ophthalmic viscous vehicle.
    Biological & pharmaceutical bulletin, 2000, Volume: 23, Issue:11

    We previously developed an in vivo pharmacokinetic model that accounts for the corneal diffusion in albino rabbits and predicts the concentration of beta-blockers in the anterior segments. The purpose of this study is to pharmacokinetically predict the ocular absorption and characterize the systemic absorption of instilled drug with ophthalmic viscous vehicle to assist in its design and evaluation. Tilisolol and carboxymethylcellulose sodium salt (CMC) were used as the model ophthalmic drug and viscous polymer, respectively. After instillation of tilisolol with CMC vehicle in rabbits, the disposition of the drug in tear fluid, aqueous humor, and plasma were determined by HPLC. The ocular and systemic absorption were analyzed by a mathematical model including a diffusion process and a two-compartment model with first-order absorption, respectively. CMC vehicle increased the area under the concentration-time curve (AUC) of tilisolol in the tear fluid and aqueous humor and slightly reduced the AUC in plasma. The concentrations of tilisolol in the aqueous humor after instillation with CMC vehicle were accurately predicted from the tear concentrations by using the in vivo ocular pharmacokinetic model. CMC vehicle improved the ocular delivery of tilisolol.

    Topics: Absorption; Adrenergic beta-Antagonists; Algorithms; Animals; Aqueous Humor; Area Under Curve; Carboxymethylcellulose Sodium; Eye; Injections, Intravenous; Isoquinolines; Male; Models, Biological; Ophthalmic Solutions; Pharmaceutic Aids; Pharmaceutical Vehicles; Rabbits; Tears; Viscosity

2000
Topical delivery system of ophthalmic drugs by periocular injection with viscous solution.
    Biological & pharmaceutical bulletin, 1999, Volume: 22, Issue:9

    The purpose of this study is to evaluate periocular injections with viscous solution as a topical delivery system of ophthalmic drugs. Tilisolol and carboxymethylcellulose (CMC) were used as a model beta-blocker and a viscous polymer, respectively. After intracapsular, retrobulbar and palpebral conjunctival injections (50 microl) of tilisolol with 3% CMC into rabbits, drug concentrations in the tear fluid, blood, aqueous humor and vitreous body were determined by HPLC. Periocular injection (50 microl) of tilisolol with 3% CMC showed slight leakage of the drug in the tear fluid from the injection site. The viscous vehicle decreased the absorption rate constant of the drug from the injection site to systemic circulation compared with the buffer solution. It suggests that the viscous solution improved the retention of drug at both the injection site and in periocular tissues. Although the periocular injections with viscous vehicle (3% CMC) showed lower AUC in the aqueous humor than that observed in instillation, they showed comparable AUC in the vitreous humor. Compared to the results after the periocular injections with buffer solution, CMC increased the AUCs in the vitreous body 3.1-fold with retrobulbar injection and 1.4-fold with palpebral conjunctival injection, respectively. As a result, periocular injections with 3% CMC showed higher delivery of tilisolol to the vitreous body against the aqueous humor than the instillation and periocular injections with buffer solution.

    Topics: Absorption; Administration, Topical; Adrenergic beta-Antagonists; Animals; Carboxymethylcellulose Sodium; Chemistry, Pharmaceutical; Drug Administration Routes; Drug Delivery Systems; Eye; Isoquinolines; Male; Ophthalmic Solutions; Rabbits

1999